Top 10 Nanotech Capital Raises and Investors in the U.S. – August 1st – 31st
Several interesting transactions closed in the Nanotech sector over the past month. If you would like more info on these deals or would like to discuss the capital raising market for your company, please contact me.
PIPE
- Grafta Nanotech, a clean technology company that uses graphene-based nanotechnology for environmental remediation, received $1.84 million of development capital through a private placement.
Merger/Acquisition
- Endurx Pharmaceuticals, a drug delivery platform that offers targeted therapeutics for hard-to-treat solid tumors and cancer, acquired by NanoRx Science.
Later Stage VC
- Duo Oncology, a clinical-stage biotechnology platform that offers precise and tolerable cancer treatments, raised $1.63 million of venture funding in the form of convertible debt financing.
- Flora Surfaces, a sustainable materials manufacturer that produces protective coatings and biobased polymers for industrial and commercial surfaces, raised $900,000 of venture funding.
- Multibeam, a semiconductor lithography equipment manufacturer that offers maskless production solutions for integrated circuits, raised venture funding from Super Capital Group.
- NanoClear Technologies, a semiconductor surface engineering technology provider that enables atomic-level precision in chip manufacturing, raised venture funding from Xcendra Ventures.
Early Stage VC
- NucleoTech, a brain-delivery carrier developer that transports advanced therapeutics across the blood-brain barrier, raised venture funding from MarketCap Investments.
Seed Round
- DexMat, a high-performance carbon materials manufacturer that produces conductive and lightweight materials for electrification applications, raised $10.25 million through a combination of Seed-1 and Seed-2 funding in a deal led by non sibi ventures.
- Discovered Materials, an AI-powered materials discovery technology provider that accelerates materials discovery for the semiconductor industry, raised $9 million of seed funding in a deal led by Lightspeed India Partners.
- InnSight Technology, an ophthalmic diagnostic device developer that enables the evaluation of eye and systemic diseases, raised $3 million of Seed funding from SOSV, Life Sciences Greenhouse Investments and Innovation Works.
#castleplacement #capitalraising #privateequity #venturecapital #investment #nanotech
Jesus Tueme
Managing Director
Finance and banking executive with a global perspective, broad professional practice and extensive network in Latin America. 22 years at BBVA, BNPP and Credit Agricole. Successful deal-making track record with multinationals, major Latin American issuers and government agencies. Extensive experience in restructuring/special situations, initial public offerings, corporate strategy, evaluating alliances, mergers and acquisitions, corporate governance, risk management, customer centric and digital strategies, and financial analytics. BS in Economics from Mexico Monterrey Institute of Technology. MBA from the University of California Los Angeles in 1987. Graduated from Harvard Business School General Management Program. Further academic work on Risk Management at Stanford University and as a research and finance scholar at the Monterrey Institute of Technology.
- Email: jtueme@castleplacement.com
- (C) (646) 479-7616
Jesus Tueme
Managing Director
Please contact me if you have any questions or would like to discuss your capital raise:
Email: jtueme@castleplacement.com
(C) (646) 479-7616
Send us a message:
Sources: Information on this page was derived from a variety of sources including Bloomberg, Company Websites, Crunchbase, PitchBook and other news outlets. Castle Placement® does not warrant or guarantee this information, nor makes any representations as to the accuracy of the information. For more Risks, see CPGO Risks and Disclaimers.
